Prognostic value of loss of heterozygosity at BRCA2 in human breast carcinoma

British Journal of Cancer

Volumn 76, Issue 11, 1997, Pages 1416-1418

  Bieche I ^a   Nogues C ^a   Rivoilan, S ^a   Khodja, A ^a   Latil, A ^a   Lidereau, R ^a  

^a CENTRE RENÉ HUGUENIN   (France)

Author keywords

BRCA2 loss of heterozygosity; Breast cancer; Prognostic value

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ARTICLE; BREAST CARCINOMA; CANCER SURVIVAL; FEMALE; HETEROZYGOSITY LOSS; HUMAN; PRIORITY JOURNAL; PROGNOSIS;

EID: 0030779737     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1997.572     Document Type: Article

References (20)

1. Beckmann MW, Picard F, An HX, Van Roeyen CRC, Dominik SI, Mosny DS, Schnürch HG, Bender HG and Niederacher D (1996) Clinical impact of detection of loss of heterozygosity of BRCA1 and BRCA2 markers in sporadic breast cancer. Br J Cancer 73: 1220-1226
2. Bieche I and Lidereau R (1995) Genetic alterations in breast cancer. Genes Chrom Cancer 14: 227-251
3. Bignon YJ, Fonck Y and Chassagne MC (1995) Histoprognostic grade in tumours from families with hereditary predisposition to breast cancer. Lancet 346: 258
4. Chen Y, Chen CF, Riley DJ, Allred DC, Chen PL, Hoff DV, Osborne CK and Lee WH (1995) Aberrant subcellular localization of BRCA1 in breast cancer. Science 270: 789-791
5. Cleton-Jansen AM, Collins N, Lakhani SR, Weissenbach J, Devilee P, Cornelisse CJ and Stratton MR (1995) Loss of heterozgosity in sporadic breast tumours at the BRCA2 locus on chromosome I3q12-q13. Br J Cancer 72: 1241-1244
6. Couch FJ, Farid LM, Deshano ML, Tavtigian SV, Calzone K, Campeau L, Peng Y, Bogden B, Chen Q, Neuhausen S, Shattuck-Eidens D, Godwin AK, Daly M, Radford DM, Sedlacek S, Rommens J, Simard J, Garber J, Merajver S and Weber BL (1996) BRCA2 germline mutations in male breast cancer cases and breast cancer families. Nature Genet 13: 123-125
7. EORTC Breast Co-operative Group (1980) Revision of the standards for the assessment of hormone receptors in human breast cancer. Report of the second EORTC workshop. Eur J Cancer 16: 1513-1515
8. Hamann U, Herbold C, Costa S, Solomayer EF, Kaufmann M, Basiert G, Ulmer HU, Frenzel H and Komitowski D (1996) Allelic imbalance on chromosome 13q: Evidence for the involvement of BRCA2 and RB1 in sporadic breast cancer. Cancer Res 56: 1988-1990
9. Kelsell DP, Spurr NK, Barnes DM, Gusterson B and Bishop DT (1996) Combined loss of BRCA1/BRCA2 in grade 3 breast carcinomas. Lancet 347: 1554-1555
10. Kerangueven F, Allione F, Noguchi T, Adelaïde J, Sobol H, Jacquemier J and Birnbaum D (1995) Patterns of loss of heterozygosity at loci from chromosome arm I3q suggest a possible involvement of BRCA2 in sporadic breast tumors. Genes Chromosom Cancer 13: 291-294
11. Lancaster JM, Wooster R, Mangion J, Phelan CM, Cochran C, Gumbs C, Seal S, Barfoot R, Collins N, Bignell G, Patel S, Hamoudi R, Larsson C, Wiseman RW, Berchuck A, Dirk Iglehart J, Stratton MR and Futreal PA (1996) BRCA2 mutations in primary breast and ovarian cancers. Nature Genet 13: 238-244
12. Maniatis T, Fritsch EF and Sambook J (1982) Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory: Cold Spring Harbor, NY
13. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W, Bell R, Rosenthal J, Hussey C, Tran T, McClure M, Frye C, Hattier T, Phelps R, Haugen-Stano A, Katcher H, Yakumo K, Gholami Z, Shaffer D, Stone S, Bayer S, Wray C, Bogden R, Dayananth P, Ward J, Tonin P, Narod S, Briston PK, Norris FH, Helvering L, Morrison P, Rosteck P, Lai M, Barrett JC, Lewis C, Neuhausen S, Cannon-Albright L, Goldgar D, Wiseman R, Kamb A and Skolnick MH (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266: 66-71
14. Miki Y, Katagiri T, Kasumi F, Yoshimoto T and Nakamura Y (1996) Mutation analysis in the BRCA2 gene in primary breast cancers. Nature Genet 13: 245-247
15. Phelan CM, Lancaster JM, Tonin P, Gumbs C, Cochran C, Carter R, Ghadirian P, Perret C, Moslehi R, Dion F, Faucher MC, Dole K, Karimi S, Foulkes W, Lounis H, Warner E, Goss P, Anderson D, Larsson C, Narod SA and Futreal AP (1996) Mutation analysis of the BRCA2 gene in 49 site-specific breast cancer families. Nature Genet 13: 120-122
16. Shattuck-Eidens D, McClure M, Simard J, Labrie F, Narod S, Couch F, Hoskins K, Weber B, Castilla L, Erdos M, Brody L, Friedman L, Ostermeyer E, Szabo C, King MC, Jhanwar S, Offit K, Norton L, Gilewski T, Lubin M, Osborne M, Black D, Boyd M, Steel M, Ingles S, Haile R, Lindblom A, Olsson H, Borg A, Bishop DT, Solomon E, Radice P, Spatti G, Gayther S, Ponder B, Warren W, Stratton M, Liu Q, Fujimura F, Lewis C, Skolnick MH and Goldgar DE (1995) A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene. JAMA 273: 535-541
17. Teng DHF, Bogden R, Mitchell J, Baumgard M, Bell R, Berry S, Davis T, Ha PC, Kehrer R, Jammulapati S, Chen Q, Offit K, Skolnick MH, Tavtigian SV, Jhanwar S, Swedlund B, Wong AKC and Kamb A (1996) Low incidence of BRCA2 mutations in breast carcinoma and other cancers. Nature Genet 13: 241-244
18. Thompson ME, Jensen RA, Obermiller PS, Page DL and Holt JT (1995) Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression. Nature Genet 9: 444-450
19. Van Den Berg I, Johannsson O, Hakansson S, Olsson H and Borg A (1996) Allelic loss at chromosome 13q12-q13 is associated with poor prognosis in familial and sporadic breast cancer. Br J Cancer 74: 1615-1619
20. Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, Collins N, Gregory S, Gumbs C, Micklem G, Barfoot R, Hamoudi R, Patel S, Rice C, Biggs P, Hashim Y, Smith A, Connor F, Arason A, Gudmundsson J, Ficenec D, Kelsell D, Ford D, Tonin P, Bishop DT, Spurr NK, Ponder BAJ, Eeles R, Peto J, Devilee P, Cornelisse C, Lynch H, Narod S, Lenoir G, Egilsson V, Barkadottir RB, Easton DF, Bentley DR, Futreal PA, Ashworth A and Stratton MR (1995). Identification of the breast cancer susceptibility gene BRCA2. Nature 378: 789-792